South African scientists have created a duplicate of the Moderna Covid vaccine, raising the potential of more people getting vaccines in poorer parts of the world.
Human trials are expected to begin in November, according to researchers in Cape Town who are endorsed by the World Health Organization.
The mRNA vaccine, which employs pieces of the coronavirus’ genetic code, was developed using publicly available information.
Moderna had previously stated that it would not enforce its vaccine patent but had declined to assist the South African initiative.
It is hoped that locally made Covid vaccines could significantly boost Africa’s poor vaccination rates, which are among the lowest in the world.
The South African team has offered to assist Latin American experts in their research.
BBC
